D. Church

发表

Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women.

K. Hamed, R. Bettis, K. Manning, 2002, Clinical therapeutics.

Comparison of Ciprofloxacin (7 Days) and Trimethoprim-Sulfamethoxazole (14 Days) for Acute Uncomplicated Pyelonephritis in Women

J. Reuning-Scherer, D. Talan, G. Moran, 2000 .

Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia.

H. Lode, S. Choudhri, D. Haverstock, 2003, Respiratory medicine.

Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.

J. Reuning-Scherer, D. Talan, G. Moran, 2000, JAMA.

The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.

A. Heyd, D. Church, C. P. Mathew, 2000, Respiratory medicine.

Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group.

A. Heyd, D. Haverstock, D. Church, 1999, Clinical therapeutics.

Efficacy and safety of sequential moxifloxacin for treatment of community-acquired pneumonia associated with atypical pathogens

D. Talan, S. Choudhri, D. Haverstock, 2004, European Journal of Clinical Microbiology and Infectious Diseases.

Cystic fibrosis clinical score: a new scoring system to evaluate acute pulmonary exacerbation.

J. Kanga, R. Kuhn, D. Haverstock, 1999, Clinical therapeutics.

Renal clearance, tissue distribution, and CA-125 responses in a phase I trial of suramin.

G. Wilding, A. Cheng, P. Hutson, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

MOXIFLOXACIN VERSUS CEPHALEXIN IN THE TREATMENT OF UNCOMPLICATED SKIN INFECTIONS

B. Miskin, L. Parish, A. Heyd, 2000, International journal of clinical practice.

Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis.

L. Nicolle, D. Talan, James X. Song, 2004, The Journal of urology.

Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.

R. Echols, J. Kanga, J. Stevens, 1997, The Pediatric infectious disease journal.

Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation.

M. V. Miles, R. Echols, J. Lettieri, 1997, The Pediatric infectious disease journal.

Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.

D. Haverstock, S. Chodosh, D. Church, 2000, Respiratory medicine.

Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia. Community Acquired Pneumonia Study Group.

J. Pearl, D. Haverstock, D. Church, 2000, Respiratory medicine.

Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia. Community Acquired Pneumonia Study Group.

J. Pearl, D. Haverstock, D. Church, 2000, Respiratory medicine.

Clinical Experience with Moxifloxacin in Patients with Respiratory Tract Infections

G. Faich, J. Morganroth, S. Kowalsky, 2004, The Annals of Pharmacotherapy.